Overview MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) has recently demonstrated a notable upward momentum, indicating potential bullish activity. The stock price has surged by 31.45%, closing at $0.8610. This analysis will delve into various technical indicators, price action, and patterns to offer a comprehensive outlook, including speculative price targets and trading strategies.
Price Action and Candle Analysis The recent candlestick formation suggests a bullish reversal, with the price closing near its high for the day. The significant increase in volume indicates strong buying interest. The stock has found support around the $0.70 level, which has been tested multiple times in the past few months.
Moving Averages The moving averages are showing mixed signals:
Short-term (10 EMA, SMA): Both the Exponential Moving Average (EMA) and Simple Moving Average (SMA) for the short term are currently in a buy zone, with the 10 EMA at $0.7492 and the 10 SMA at $0.7354. Medium-term (30 EMA, SMA): The 30 EMA is at $0.8272, while the 30 SMA is at $0.8169, both indicating a potential buy signal. Long-term (200 EMA, SMA): Both the 200 EMA ($2.4360) and 200 SMA ($2.4190) are in sell territory, suggesting that the long-term trend is still bearish.
Oscillators and Momentum Indicators Relative Strength Index (RSI): The RSI is at 55.3788, indicating neutral momentum but leaning towards bullish territory. MACD: The MACD level (12, 26) is at -0.0560 with a bullish crossover, suggesting a potential continuation of the upward momentum. Stochastic Oscillator: The %K value is 32.3012, indicating the stock is not overbought, providing room for further upward movement.
Volume Analysis The volume has significantly increased to 1.78M, which is above the 30-day average of 106.04K. This surge in volume supports the bullish sentiment and indicates strong investor interest.
Support and Resistance Levels Immediate Support: $0.70 (tested multiple times and held firm) Immediate Resistance: $0.90 (near the current price level) Key Resistance Levels: $1.00, $1.05 (R1), and $1.27 (R2)
Earnings and Valuation Metrics Next Earnings Report: Approximately 100 days from now (around August 28, 2024) Market Capitalization: 9.68M EPS (TTM): -$0.81 Shares Float: 9.76M
Trading Strategy and Price Prediction Given the current technical setup and momentum:
Long Position: Consider entering a long position if the price breaks and sustains above $0.90. Set a stop loss at $0.70 to manage downside risk. Target price levels are $1.05 (R1) and $1.27 (R2).
Short Position: If the price fails to hold above $0.70, consider shorting with a stop loss at $0.90. Target price levels are $0.55 (S2) and $0.30 (below S3). Speculative Price Targets
Bullish Scenario: If bullish momentum continues and the stock breaks above $1.05, it could potentially reach $1.27 in the near term. A breakout above $1.27 could see the stock test the $1.63 level. Bearish Scenario: If bearish pressure prevails and the stock drops below $0.70, the next support levels are $0.55 and $0.30.
Conclusion MIRA Pharmaceuticals, Inc. shows potential for a bullish breakout given the recent price action and volume surge. However, traders should monitor key support and resistance levels closely. The recommended strategy is to enter long positions on a confirmed breakout above $0.90 with a stop loss at $0.70. Conversely, short positions could be considered if the price fails to hold above $0.70. As always, manage risk appropriately and stay updated with the latest market news and technical signals.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.